The analysis showed that patients with rosacea had significantly higher levels of MMP-9 compared with controls (764.52 ± 569.83 pg/mL vs. 260.69 ± 170.43 pg/mL, p < 0.05). This evidence concerns the gene MMP9 and rosacea.